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Abstract. We investigated a haemopoietic stromal defect, in mice heterozygous for 
the Slj allele, during haemopoietic stress induced by treatment with bacterial 
lipopolysaccharides (LPS) or lethal total body irradiation (TBI) and bone-marrow 
cell (BMC) reconstitution. Both treatments resulted in a comparable haemopoietic 
stem cell (CFU-s) proliferation in Sli/+ and +/+ haemopoietic organs. There was no 
difference in committed haemopoietic progenitor cell (BFU-e and CFU-G/M) kinetics 
after TBI and +/+ bone-marrow transplantation in Slj/+ and +/+ mice. The Slj/+ 
mice were deficient in their ability to support macroscopic spleen colony formation 
(65% of +/+ controls) as measured at 7 and 10 days after BMC transplantation. 
However, the Slj/+ spleen colonies contained the same number of BFU-E and 
CFU-G/M as colonies from +/+ spleens, while their CFU-s content was increased. 
On day 10 post-transplantation, the macroscopic ‘missing’ colonies could be detected 
at the microscopic level. These small colonies contained far fewer CFU-s than the 
macroscopic detectable colonies. Analysis of CFU-s proliferation-inducing activities 
in control and post-LPS sera revealed that SP/+ mice are normal in their ability to 
produce and to respond to humoral stem-cell regulators. 
We postulate that Slj/+ mice have a normal number of splenic stromal ‘niches’ for 
colony formation. However, 35% of these niches is defective in its proliferative 
support. 
The S1’ allele has been demonstrated to have effects upon haemopoiesis in homozygous fetuses 
(Cole et al., 1974), and in allophenic mice (Mintz & Cronmiller, 1978). Adult mice, 
heterozygous for the Slj allele, are haematologically characterized by a mild normochromic 
macrocytic anaemia and a quantitative deficiency of haemopoietic stem cells (CFU-s), early 
erythroid progenitors (BFU-e) and granulocyte/macrophage progenitors (CFU-G/M) 
(Ploemacher & Brons, 1984; Brockback & Ploemacher, 1983). When Slj/+ mice are used as 
recipients for the CFU-s assay 30% fewer macroscopic spleen colonies are formed than in 
normal +/+ controls, and this deficiency is not due to defective CFU-s lodgment in the spleen 
(Ploemacher & Brons, 1984). Furthermore, ectopically implanted S1’/+ spleens support less 
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CFU-s than +/+ spleens (Ploemacher & Brons, 1984). These observations led us to propose 
that there is a defective microenvironmental support for colony formation in the Slj/+ spleen. 
The spleen in normal adult mice responds to bacterial lipopolysaccharide (LPS) treatment 
with a large burst of haemopoietic activity at 4-7 days later (McCulloch et aZ., 1970; Vos, 
Buurman & Ploemacher, 1972). It has been reported that the severely anaemic S1/Sld mice are 
not able to support the extensive splenic CFU-s accumulation observed in normal littermates 
upon LPS injection (Ploemacher et al., 1983a) or to sustain CFU-s proliferation following 
lethal total body irradiation (TBI) and bone-marrow transplantation (McCdloch et al., 1965). 
Production of humoral regulators of CFU-s proliferation, i.e. stem-cell activating factors 
(SAF; Dicke, van den Engh & Lowenberg, 1974; Cerny, Warner & Rubin, 1975; Lowenberg 
& Dicke, 1977) and splenic haemopoiesis stimulating factor (SHSF, Staber & Metcalf, 1970), 
in response to LPS treatment, was normal in Sl/Sld mice (Ploemacher et al., 1983a). The 
failure of S1/Sld mice to respond to bacterial LPS was attributed to a refractory response of 
these mice to humoral regulators of CFU-s proliferation. 
In this investigation we have studied the ability of Slj/+ mice to support proliferation of 
haemopoietic stem cells and progenitor cells in haemopoietic stress situations and analysed 
their ability to produce and to respond to humoral regulators of CFU-s proliferation. 
M A T E R I A L S  A N D  M E T H O D S  
Animals 
Strain 129 and SvSlj CP mice of both sexes were bred at the Laboratory Animals Centre 
of the Erasmus University, Rotterdam. The origins of maintenance conditions of these mice 
have been described (Ploemacher & Brons, 1984). 
Assays for in vivo colony formation and progenitor cell growth 
A Gammacell 40 13’Caesium Irradiation unit (Atomic Energy of Canada Ltd, Ottawa) was 
used at a dose rate of 1.3 Gy/min. The CFU-s assay of Till & McCulloch (1961) was 
performed using 8.5 Gy total body irradiated SP/+ and +/+ mice as recipients. Growth 
kinetics of progenitor cells were determined according to the retransplantation method of 
Siminovitch, Till & McCulloch 1964). Briefly, 5 x lo6 femoral bone-marrow cells (BMC) 
from pools of three +/+ mice were injected intravenously (i.v.) into three or four intermediate 
recipients with SIj/+ or +/+ gene complements. At days 4, 7 and 10 these mice were killed, 
their spleens and femurs removed and single cell suspensions prepared. The CFU-s content of 
the suspensions was determined using the in uivo spleen colony assay while BFU-e and 
CFU-G/M were quantified in vitro in a semi-solid medium as previously described 
(Brockbank & Ploemacher, 1983). Diameters of surface colonies on spleens fixed in Bouin 
Hollande’s fluid were estimated in tenths of a mm, using an inverted microscope and a 
fine-scale transparent matrix. 
In order to determine the CFU-s distribution among macroscopic spleen colonies, 1 x lo4 
nucleated +/+ BMC were injected i.v. into lethally irradiated +/+ and Slj/+ mice to give 
about two macroscopic colonies in any one +/+ spleen and about one in Slj/+ spleens. Ten 
days later, individual colonies were dissected out of the spleen and assayed for their content of 
CFU-s. A logarithmic conversion of the data was used in calculating the mean colony CFU-s 
content to correct for the skewed distribution of CFU-s among the colonies (Siminovitch et 
al., 1964). Spleen parts that were free of colonies on gross inspection were also assayed for 
their CFU-s content. 
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Preparation of post-LPS serum and normal serum 
Mice were injected intraperitoneally (i.p.) with 500 pg of Salmonella typhosa lipo- 
polysaccharide (prepared according to Westphal) in a buffered saline solution (BSS) or with 
BSS alone. Six hr later, cardiac blood was obtained by a sterile procedure and clotting was 
allowed for 1 hr at room temperature. After storage at 4°C overnight, the post-lipopoly- 
saccharide serum (PLPSS) and normal mouse serum (NMS) were collected by two consecu- 
tive centrifugations at 500 g and stored at -2OOC until use. The level of residual endotoxin 
in the sera was estimated in the Limulus lysate assay as described by Levin et al. (1970). 
Detection system for stem-cell activating factor (SAF) and splenic haemopoiesis stimulating 
factor (SHSF) 
The assay used to detect SAF is based on the prolonged maintenance of proliferating CFU-s 
in suspension culture, as compared to quiescent CFU-s (Dicke et al., 1974; Cerny et al., 
1975; Lowenberg & Dicke, 1977). SAF was detected by the assay of Wagemaker, Merchav 
& Burger (1 982). SAF (Concanavalin-A-stimulated mouse spleen conditioned medium, 
MSCM stage III), purified by affinity chromatography, gel filtration and ion exchange 
chromatography using DEAE-sepharose at pH 8.0, was a gift from Dr G. Wagemaker, 
Rijswijk, the Netherlands. These procedures increased the specific activity to about 
82,000-fold and the preparation contained approximately 40% of the SAF activity of the 
original MSCM. Duplicate cultures of 6 x lo5 nucleated bone-marrow cells (BMC) were 
incubated for 4 days in a volume of 1 ml in loosely capped plastic tubes (Falcon No. 2057) at 
37°C and an atmosphere of 5% CO, in air. The medium consisted of a medium, 
supplemented with 0.25 w/v delipidated BSA (Sigma), 4 x M human transferrin-2Fe 
(Behringwerke), lo-’ M Na,SeO, (Koch Light), lop4 M p-mercaptoethanol (Merck), M 
isoproterenol (Sigma), lop6 M hydrocortisone-hemisuccinate (Sigma), g/I nucleosides 
(adenosine, cytosine, guanine, uridine, thymidine, 2’ deoxyguanosine, 2‘ deoxyadenosine and 
2’-deoxycytosine) and 1.125 x lo-’ M cholesterol (Calbiochem). 
The serum content (Staber & Metcalf, 1980) of splenic haemopoiesis stimulating factor 
(SHSF) was quantified in viuo by measurement of the splenic CFU-s accumulation at 4 days 
after i.p. injection of 0.3 ml serum. 
RESULTS 
Growth characteristics of haemopoietic precursors in lethally irradiated Sg/+ and +/+ mice 
Figure 1 shows the cellularity of spleen and femur in Slj/+ and +/+ mice on days 4, 7 and 10 
following lethal whole body irradiation and i.v. injection of 5 x lo6 +/+ BMC. Between days 
4 and 10, the growth of +/+ BMC in SP/+ organs was essentially the same as in +/+ organs 
when measured by the organ cellularity. Normal values for unirradiated animals showed a 
slightly reduced femoral cellularity in Slj/+ mice, in agreement with previously published 
findings (Ploemacher & Brons, 1984). 
It appears that the growth of CFU-s, BFU-e and CFU-G/M is essentially the same in 
SP/+ and +/+ organs (Fig. 2), despite the fact that Slj/+ mice showed a reduced spleen 
colony formation when injected with the proper number of BMC (Table 1). When the CFU-s 
growth data is expressed as a percentage of normal organ CFU-s content (Fig. 3), the growth 
of +/+ BMC-derived CFU-s is noticeably well supported in Slj/+ spleen and femurs. The 
same can be concluded for the growth kinetics of BFU-e and CFU-G/M (not indicated in 
figures). 
Injection of 4 x lo4 +/+ BMC into Slj/+ mice led to a diminished spleen colony 
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Fig. I. Growth curve of +/+ BMC in 
the spleen (A, A) and femurs (0, 0) of 
SIJ+ (0, A) and +/+ (0, A) mice. At 
day 0, 5 x lo6 BMC were injected i.v. 
The arithmetic mean (fs.e.m.) of nine 
individually assayed mice in three separ- 
ate experiments are given. 
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Fig. 2. Growth curve for CFU-s (A), BFU-e (0) and CFU-G/M (0) in the femur and spleens of SIJ/+ and +/+ 
mice. At day 0, 5 x lo6 +/+ BMC were injected i.v. Presented are the arithmetic means of three separate 
experiments to which a total of nine mice contributed. 
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Recovery in 
% of normal 
CFU-s content 
Fig. 3. Growth curve for +/+ CFU-s in the spleen 10-1 J r I I I I I 
(A, A) and femurs (0, 0)  of SIJ/+ (0, A) and 0 2 4 6 8 10 
+/+ (a, A) mice. Analysis as for Fig. 2. Doys ofter tronsplontotion 
formation as compared to that in +/+ spleens (Table 1). The size of the Slj/+ spleen colonies 
on day 7 (not indicated in table) was not significantly different from colonies found on +/+ 
spleens, as estimated by measurement of the diameter of the four largest surface colonies per 
spleen. Colonies on Slj/+ spleens had a mean diameter (k 1 SE) of 1.03 f 0-03 mm, while 
+/+ colonies measured 1.12 k 0.03 mm. BFU-e and CFU-G/M numbers in individual days 
7 and 10 colonies were the same in SlJ/+ spleens as in +/+ spleens; however, consistently 
higher CFU-s numbers were observed in SIJ/+ colonies (Table 1). From Table 1 it would also 
appear that at least half of the CFU-s contained in any spleen on day 10 is not found within 
macroscopic spleen colonies, but is localized in parts of the spleen in which no colonies could 
be detected on gross inspection. 
Microscopic inspection revealed a decrease of the day 7 microscopic colony formation in 
SlJ/+ spleens, apparent on gross inspection of the spleen. At 10 days the number of 
macroscopically detectable colonies in Slj/+ spleens was 53-65% of the colony formation in 
+/+ spleens, whereas no reduction of microscopic colonies was noticed (Table 2). This 
observation indicates that the development of the ‘missing’ colonies had been delayed to such 
an extent that their size was too small to meet the limits for their detection on the spleen 
surface. If all CFU-s that were retrieved from parts of the spleen that did not contain colonies 
on gross inspection (Table 1) were contained in microscopic colonies (Table 2), then SV/+ 
mice would have a lower CFU-s content of their microscopic spleen colonies, as compared to 
+/+ mice. 
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Table 2. Types of haemopoietic colonies as detected in SIJ/+ and +/+ spleens at 7 and 10 days after irradiation 
(8 .5  Gy) and grafting of 3 x lo4 +/+ bone-marrow cells 
Percentages of different histologic types 
of colonies* Colonies/spleen (1 + SE) 
Recipient Day of No. of 
genotype observation mice Macroscopic Microscopic EI EII EIII G M U + Mix 
+I+ 7 65 5.14(0.20)? 6.61 (0.27) 24.2 33.4 23.1 2.3 2.8 14.1 
SI!/+ 7 61 3.28(0*11) 4.55(0.09) 20.4 37.8 23.0 3.0 1.5 14.4 
+/+ 10 61 4.08(0.27) 5.44(0.15) 9.9 41.3 14.1 15.0 4.2 15.5 
SI’/+ 10 62 2’90(0.13) 5.47 (0.35) 9.9 41.0 14,6 11.4 7.9 15.5 
~ ~~~ 
* Abbreviations for the colony types are: EI, erythrocytic colonies containing less than 20% normoblasts; 
EII, between 20 and 80% normoblasts; EIII, more than 80% normoblasts: G, granulocytic, M, megakaryocytic; 
U + Mix, undifferentiated + mixed type. 
t All figures represent means (k 1 SE) of data collected in four separate experiments. 
CFU-s praliferation in the spleen following LPS-W injection 
Groups of three to four mice were injected i.v. with various doses of LPS-W and analysed 
4 days later. The +/+ mice reached a plateau level of splenic CFU-s and cellularity at 30 pg 
LPS-W, indicating that this dose already maximally stimulated CFU-s proliferation in the 
spleen within this time period (Table 3). SlJ/+ mice, which normally have only 3 5 4 0 %  of the 
Table 3. CFU-s accumulation in the spleen of 129 SIJ/+ and +/+ mice 
4 days after lipopolysaccharide injection 
Dose CFU-s Cellularity (x 10’) 
0 4013 (I85)t 1535 (437) 17.5 (1.0)$ 15.3 (0.6) 
30 37,158 (1673) 23,555 (4060) 28.9 (0.9) 25.4 (0.9) 
100 35,389 (6546) 35,137 (3716) 30.9 (1.2) 27.5 (1.0) 
300 41,196 (6349) 15,803 (4112) 27.9 (2.6) 24.8 (2.3) 
* LPS-W from Salmonella typhosa. 
t Arithmetic mean (21  SE) of three separate experiments in which a 
4 Arithmetic mean (k 1 SE) of eleven individually assayed mice in three 
total of eleven mice were tested. 
separate experiments. 
splenic CFU-s content observed in +/+ littermates, showed a comparable rise in cellularity 
and CFU-s numbers. A maximal stimulating effect was found using 100 pg of LPS. These 
observations indicate that LPS changes the proliferative status of CFU-s in the spleen 
(McCulloch et al., 1970) of +/+ and Slj/+ mice to a similar extent. 
Quantification of stem-cell activating factor (SAF) and splenic haemopoiesis stimulating 
factor (SHSF) 
The 4-day survival of normal +/+ CFU-s in a serum-free suspension culture was negligible 
(Table 4). In the presence of 10 pl of SAF, the CFU-s recovery exceeded that of the inoculum 
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Table 4. Effects of serum from normal or LPS-W- 
injected 129 SP/+ or +/+ mice on CFU-s 
proliferation in vitro 
CFU-s recovery (% inoculum) 
Serum 
added* Exp. I Exp. I1 
None 0 
S A F t  1 3 1 . 3  (3.5)$ n.d. 
+I+ NMS 0 0 
SIJ/+ NMS 0 0 
+/+ PLPSS 78.3 (8.7) 68.7 (10.1) 
SI’/+ PLPSS 79.8 (7.1)  56.5 (9.3) 
50 pl of normal mouse serum (NMS) or post- 
LPS-W serum (PLPSS) was added to 1 ml of 
otherwise serum-free culture medium. Cultures 
were in duplicate. 
t 10 pl of stage I11 MSCM instead of serum 
was added. 
$ Arithmetic mean (k 1 SE) of spleen colony 
assay on ten mice. 
value. The addition of NMS from both +/+ and Slj/+ mice did not enhance CFU-s survival. 
However, PLPSS from +/+ and Slji+ mice were similarly effective in activating CFU-s 
proliferation in vitro. 
In contrast to the inactivity of NMS in vitro, in vivo administration induced a significant 
rise in splenic CFU-s numbers in both +/+ and SIJ/+ recipient mice (Table 5 ) .  Contrary to 
the significantly lower activity of Slj/+ NMS as compared to +/+ NMS, SP/+ PLPSS 
induced a larger splenic CFU-S accumulation in recipient mice than +/+ PLPSS. These 
observations demonstrate that there is no deficiency of SHSF production in SV/+ mice 
Table 5.  Effects of serum from normal LPS-W- 
injected 129 SI’/+ or +/+ mice on spleen CFU-s 
levels in SlJ/+ and +/+  mice 
Splenic CFU-s content ( x  lo5)  
Serum 
injected* +/+  mice SP/+ mice 
None 4 . 2  (1. l )I’  1.8 (0.5) 
BSS 7.0 (1.7)  4 . 3  (0.5) 
+i+ NMS 12.7 (1.4) 5 .3  (0.8) 
+I+ PLPSS 28.1 (4.3)  23.7 (5.9) 
SlJ/+ NMS 8 .1  (0.4) 2.5 (0.7) 
SI’/+ PLPSS 49.8 (4.9) 35.6 (5.9)  
* 0 . 3  ml of serum or BSS was injected i.p. 
Mice were killed at day 4. NMS. normal mouse 
serum; PLPSS, post-LPS-W serum: BSS, 
buffered saline solution. 
t Arithmetic mean (i- 1 SE) of three in- 
dividually assayed mice. 
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following treatment with LPS. Furthermore, Slj/+ mice have an excellent response to SHSF 
contained in injected serum (Table 5).  Analysis of PLPSS by the Limulus amoebocyte lysate 
assay indicated the presence of 0.1 pg of LPS per ml of PLPSS. This amount of LPS could 
not have led to the observed increases in splenic CFU-s numbers. 
DISCUSSION 
The objective of the experiments reported in this paper was to investigate the control of 
CFU-s proliferation in microenvironmentally defective Slj/+ mice and in their normal +/+ 
littermates. We have previously shown that treatment with LPS can be used as a probe to 
reveal defective splenic stromal support for CFU-s proliferation (Ploemacher et al., 1983a,b). 
Thus S1/Sld mice, as well as reconstituted irradiated normal mice, demonstrated a deficient 
splenic CFU-s and a haemopoietic progenitor cell accumulation in response to LPS. We now 
show that Slj/+ mice, which have a significantly reduced splenic CFU-s number when 
compared with their normal +/+ littermates, are able to mount a relatively normal splenic 
CFU-s increase in response to treatment with LPS. Similarly, CFU-s, BFU-e and CFU-G/M 
exhibited normal repopulation kinetics after TBI and +/+ bone-marrow cell (BMC) grafting 
in SV/+ haemopoietic organs. However, +/+ BMC formed fewer macroscopic colonies in 
SP/+ spleens when measured on days 7 and 10, while progenitor cell accumulation was 
normal and CFU-s renewal was even higher in Slj/+ spleen colonies than in +/+ spleen 
colonies. The reduction of the microscopic colony number detected on day 7 was not present 
on day 10. This observation indicates that about 35% of all microscopic colonies that were 
observed on day 10 were not detectable on day 7 and therefore had undergone a severely 
delayed development or restricted proliferation. In view of this, we propose that the Slj/+ 
splenic niches for macroscopic colony formation are deficient in number but not in quality. In 
addition, one-third of all niches is qualitatively deficient and only supports microscopic colony 
formation over a 10-day period. The data in Tables 1 and 2 suggest that these microscopic 
colonies contain fewer CFU-s when determined on day 10. Since the differential colony 
counts (Table 2) did not reveal a preponderance of undifferentiated or early erythroid (EI) 
colonies in S11/+ spleens on day 10, it is also implied that the small microscopic colonies were 
not delayed in their differentiation, but had undergone limited proliferation, and therefore were 
too small to be detected at day 7. It should be noted that the term ‘niche’ is not used here as 
qualified by Schofield (1978) who characterized it as a site in which stem cells are not 
susceptible to differentiating stimuli. 
We have presented evidence that Slj/+ mice, in contrast with previous .reports on S1/Sld 
mice (McCulloch et al., 1970; Ploemacher et al., 1983a) are able to respond to LPS injection 
with a splenic CFU-s accumulation comparable to +/+ mice. Bacterial LPS elicits a rise in 
serum SHSF levels (Staber 62 Metcalf, 1980). We have previously demonstrated that an 
activity, present in post-LPS serum, triggers CFU-s to proliferate in uitro, in addition to the in 
uiuo active SHSF (Ploemacher et al., 1983a). This stem-cell activating factor (SAF) has been 
operationally equated with SHSF in this work. The observation that the SAF level was not 
different in PLPSS derived from +/+ and Slj/+ mice, whereas the SHSF level was 1.5-2.0 
times higher in Slj/+ PLPSS than in +/+ PLPSS, suggests that these two biological activities 
may be produced by different substances. We have shown that Slj/+ mice, similar to S1/Sld 
mice (Ploemacher et al., 1983a), respond to LPS with normal production of humoral CFU-s 
proliferation regulators. However, in contrast with Slj/+ mice, the splenic stroma of Sl/Sld 
mice is unable to provide sufficient support for the proliferation and differentiation of CFU-s 
(McCulloch et al., 1965, 1970; Ploemacher et al., 1983a) and for macroscopic spleen colony 
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formation (Altus et al., 1971). An interesting observation in this respect is that of Wolf 
(1974), who studied the development of spleen colonies in 900 R irradiated SI/Sld and +/+ 
mice at 8 days following injection with 5 x lo4 +/+ BMC. The +/+ animals were found to 
have developed the expected number of macroscopic colonies, whereas the S1/Sld mice 
developed none. However, upon careful inspection of subserial histologic sections, it was seen 
that many small haematopoietic colonies had developed, totalling one-third of the microscopic 
colony number in +/+ spleens. These observations suggest that Sl/Sld mice not only have a 
quantitative deficiency of niches for colony formation, but also suffer from a qualitative defect 
of the remaining niches, leading to diminished proliferation of CFU-s and their progeny in any 
one colony. If this were true, the expression of the Slj/+ genotype on the level of CFU-s 
proliferation would qualitatively differ from that of the Sl/Sld allele combination. 
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